Amber Orman, MD

Dr. Amber Orman is an Assistant Member in the Department of Radiation Oncology, with a secondary appointment in the Department of Oncologic Sciences at the University of South Florida. Dr. Orman’s clinical focus is breast cancer, with an emphasis on holistic care that encompasses both mind and body. Dr. Orman’s primary research interest is in integrative therapies and their applications to cancer prevention, treatment and survivorship. She is especially focused on nutrition and the microbiome. Dr. Orman graduated summa cum laude from Rose-Hulman Institute of Technology with a degree in Applied Biology. Upon graduation, she received the John T. Royse Award, which is presented to the senior who on the basis of academic achievement, student leadership, and citizenship is considered by the faculty and staff to be the most outstanding graduate. Dr. Orman then received her MD degree from the Indiana University School of Medicine in Indianapolis. There, she was awarded with the John H. Edwards Fellowship, one of Indiana University’s most prestigious academic awards based on good citizenship, character, scholastic ability and intellectual capacity. She then completed her Radiation Oncology residency at the University of Miami Miller School of Medicine, where she served as Chief Resident. Dr. Orman has published on a wide variety of topics including prostate cancer, pediatric retinoblastoma, occult primary breast cancer, and head and neck cancer, and she has presented research at multiple national meetings. For her accomplishments, she was awarded the Radiological Society of North America Roentgen Resident/Fellow Research Award. She joined the Moffitt Cancer Center Department of Radiation Oncology Breast Section in 2015. Dr. Orman believes in treating not only the cancer at hand, but also the whole patient. She believes in interventions that improve outcomes as well as quality of life, both during and after treatment. Dr. Orman also focuses on health promotion strategies during cancer survivorship, with the goals of decreasing the risk of a subsequent battle with cancer, minimizing co-morbidities, and improving overall health long term.  

Provider

Amber Orman, MD

Radiation Oncology

Call 1-888-Moffitt
(1-888-663-3488)
For an Appointment

Schedule Appointment

Program
Radiation Oncology

Print Print Physician Bio

Education & Training

BOARD CERTIFICATION:
    RESIDENCY:
    • St. Vincent Hospital - Transitional Medicine
    • University of Miami Miller School of Medicine - Radiation Oncology
    MEDICAL SCHOOL:
    • Indiana University School of Medicine - MD
    Provider

    Amber Orman, MD

    Radiation Oncology

    Call 1-888-Moffitt
    (1-888-663-3488)
    For an Appointment

    Schedule Appointment

    Program
    Radiation Oncology

    Print Print Physician Bio

    Publications

    • Mellon EA, Orman A, Joya LE, Montejo ME, Laronga C, Hoover SJ, Lee MC, Khakpour N, Kubal PF, Diaz R. Frequency of whole breast radiation therapy after intraoperative radiation therapy due to criteria identified by lumpectomy. Brachytherapy. 2016 Nov;16(1):174-180. Pubmedid: 27816540.
    • Bossart EL, Stoyanova R, Sandler K, Studenski M, Orman A, Abramowitz M, Pollack A. Feasibility and Initial Dosimetric Findings for a Randomized Trial Using Dose-Painted Multiparametric Magnetic Resonance Imaging-Defined Targets in Prostate Cancer. Int J Radiat Oncol Biol Phys. 2016 Jun;95(2):827-834. Pubmedid: 27020109.
    • Ahmed AA, Holliday EB, Ileto J, Yoo SK, Green M, Orman A, Deville C, Jagsi R, Haffty BG, Wilson LD. Close to Home: Employment Outcomes for Recent Radiation Oncology Graduates. Int J Radiat Oncol Biol Phys. 2016 Jul;95(3):1017-1021. Pubmedid: 27302515.
    • Orman A, Markoe A, Johnstone PA. Leptomeningeal failure of retinoblastoma. Pediatr Blood Cancer. 2015 Mar;62(3):533-535. Pubmedid: 25262657.

    Provider

    Amber Orman, MD

    Radiation Oncology

    Call 1-888-Moffitt
    (1-888-663-3488)
    For an Appointment

    Schedule Appointment

    Program
    Radiation Oncology

    Print Print Physician Bio

    Participating Trials

    CLINICAL TRIAL 18356
    A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients who have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
    Condition: Breast
    Intervention:
    Open

    CLINICAL TRIAL 18386
    A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy
    Condition: Breast
    Intervention: Not Applicable
    Open

    CLINICAL TRIAL 18201
    A Phase I Dose Escalation Study of Preoperative Stereotactic Body Radiation Therapy (SBRT) for High Risk Prostate Cancer
    Condition: Genitourinary
    Intervention: Not Applicable
    Open

    CLINICAL TRIAL 18596
    A Phase II Study of Preoperative Stereotactic Ablative Body Radiotherapy (SABR) for Early-Stage Breast Cancer: Introduction of a Novel Form of Accelerated Partial Breast Radiotherapy
    Condition: Breast
    Intervention: Not Applicable
    Open

    If you believe you are eligible for one of these trials or studies, please call
    1-888-MOFFITT (1-888-663-3488).


    Provider

    Amber Orman, MD

    Radiation Oncology

    Call 1-888-Moffitt
    (1-888-663-3488)
    For an Appointment

    Schedule Appointment

    Program
    Radiation Oncology

    Print Print Physician Bio